Microbot Medical to Share Current Results of a Feasibility Animal Study Utilizing the LIBERTY Robotic System
Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference
HINGHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference, being held on Monday, August 17, 2020, Microbot Medical Inc . (Nasdaq: MBOT ), will provide initial results of a feasibility animal study performed using the Company’s LIBERTY Robotic System.
On 1/13/20, H.C. Wainwright maintained a Buy rating on MBOT and raised the price target from $12 to $26.00.
I think this device could be a game changer.
Disposable medical devices is where the future is going especially for sanitary reasons.
Watch this stock Monday, 8/17/2020, it could run hard.
I think the stock has been consolidating for a while and is coiling and ready to explode higher.
The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.